Fine Chemicals: Growth Amid Pricing Pressure

The global pharmaceutical industry is expected to grow 5%-7% in 2011, and sales will exceed $880 billion, consulting firm IMS Health (Norwalk, CT) says. “While the overall market will appear to rebound somewhat in 2011, the underlying constraints to growth in developed markets are stronger than ever, including the impact of major patent expiries and payer mechanisms to limit drug spending,” says Murray Aitken, senior v.p. at IMS Health. Products with combined sales of more than $30 billion/year face the prospect of competition from generic versions in the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers